Clinical Trials Sponsored by Hangzhou Cancer Hospital

Total 11078 results

Hangzhou Cancer Hospital

Recruiting

CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

Esophageal Diseases | Esophageal Squamous Cell Carcinoma | Esophageal Neoplasm

China
Hangzhou Cancer Hospital

Unknown

Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.

Esophageal Cancer | Endostatin

China
Hangzhou Cancer Hospital

Unknown

Apatinib for Metastatic Esophageal Cancer.

Esophageal Cancer | Apatinib | Metastatic Esophageal Cancer

China
Hangzhou Cancer Hospital

Unknown

RT Plus EGFR-TKI for Wild-type NSCLC

Non-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)

China
Hangzhou Cancer Hospital

Completed

CCRT for Esophageal Cancer.

Esophageal Cancer | Paclitaxel | Concurrent Chemoradiotherapy | Oxaliplatin
Hangzhou Cancer Hospital

Unknown

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Esophageal Cancer | Stereotactic Body Radiation Therapy | Metastatic Esophageal Cancer | Thymalfasin

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer | Brain Metastases | Stage IV Non-small Cell Lung Cancer

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Non Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLC

China
Zhejiang Cancer Hospital
Hangzhou Cancer Hospital

Unknown

Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases

NSCLC
Shixiu Wu

Recruiting

Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer

Pancreatic Cancer

China
Shixiu Wu

Unknown

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Digestive System Diseases | Esophageal Neoplasms | Esophageal Diseases

China
Fuda Cancer Hospital, Guangzhou

No longer available

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms (IRE)

Head and Neck Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli (IRE)

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function

Hepatic Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve) (IRE)

Lymph Node Metastases

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms (IRE)

Urinary Bladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms (IRE)

Laryngeal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms (IRE)

Extremities Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms (IRE)

Stomach Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

CAR-T Cell Immunotherapy | EphA2 Positive Malignant Glioma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

CAR-T Cell Immunotherapy | Glioma of Brain
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Liver Cancer

Pain | Liver Neoplasms | Cancer Pain

China
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Pancreatic Cancer

Pain | Pancreatic Cancer | Cancer Pain

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient

Breast Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient

Prostatic Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Renal Tumors (IRE)

Renal Tumor

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms (IRE)

Hilus Pulmonary Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms (IRE)

Uterine Cervical Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder

Hepatic Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroportion for Unresectable Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency (IRE)

Lung Neoplasms Accompanied by Respiratory Function Insufficiency

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for HCC Targeting GPC3

CAR-T Cell Immunotherapy | GPC3 Positive Hepatocellular Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms (IRE)

Prostatic Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Lung Neoplasms
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient

Lung Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

Liver Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms (IRE)

Gallbladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Rectal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms (IRE)

Esophageal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Liver Cancer

China

Clinical Trials Sponsored by Hangzhou Cancer Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations